Spark Therapeutics Inc (ONCE):企業の財務・戦略的SWOT分析

◆英語タイトル:Spark Therapeutics Inc (ONCE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH500663FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1. The company’s gene therapy vectors used in its programs are engineered using adeno-associated virus. Spark’s SPK-RPE65 is intentended to cure rare blinding conditions caused by mutations in the RPE65 gene. The company develops gene therapy products for the treatment of debilitating genetic diseases such as inherited retinal dystrophies, hematologic disorders and neurodegenerative diseases. It collaborates with pharma and biotech companies for its research and development activities. Spark is headquartered in Philadelphia, Pennsylvania, the US.

Spark Therapeutics Inc Key Recent Developments

Feb 25,2021: Spark Therapeutics further strengthens technical expertise with appointment of Cynthia Pussinen as Chief Technical Officer
Feb 01,2021: Spark Therapeutics Announces First Participant Dosed in Phase 1/2 Study of Investigational Gene Therapy for Late-Onset Pompe Disease
Nov 16,2020: Spark Therapeutics expands visionary leadership with appointment of Michael Retterath as Chief Strategy Officer
Aug 10,2020: Spark Therapeutics deepens drug development expertise in hematology and rare disease with appointment of Gallia G. Levy, M.D., Ph.D., as Chief Medical Officer
Jun 01,2020: Study demonstrating role of IdeS in enabling of gene therapy in the presence of neutralizing anti-AAV antibodies published in Nature Medicine

This comprehensive SWOT profile of Spark Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Spark Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Spark Therapeutics Inc – Key Information
Spark Therapeutics Inc – Overview
Spark Therapeutics Inc – Key Employees
Spark Therapeutics Inc – Key Employee Biographies
Spark Therapeutics Inc – Key Operational Heads
Spark Therapeutics Inc – Major Products and Services
Spark Therapeutics Inc – History
Spark Therapeutics Inc – Company Statement
Spark Therapeutics Inc – Locations And Subsidiaries
Spark Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Spark Therapeutics Inc – Business Description
Spark Therapeutics Inc – Corporate Strategy
Spark Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Spark Therapeutics Inc – Strengths
Spark Therapeutics Inc – Weaknesses
Spark Therapeutics Inc – Opportunities
Spark Therapeutics Inc – Threats
Spark Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Spark Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Spark Therapeutics Inc, Key Information
Spark Therapeutics Inc, Key Ratios
Spark Therapeutics Inc, Share Data
Spark Therapeutics Inc, Major Products and Services
Spark Therapeutics Inc, History
Spark Therapeutics Inc, Key Employees
Spark Therapeutics Inc, Key Employee Biographies
Spark Therapeutics Inc, Key Operational Heads
Spark Therapeutics Inc, Other Locations
Spark Therapeutics Inc, Subsidiaries
Spark Therapeutics Inc, Key Competitors
Spark Therapeutics Inc, SWOT Analysis
Spark Therapeutics Inc, Ratios based on current share price
Spark Therapeutics Inc, Annual Ratios
Spark Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Spark Therapeutics Inc (ONCE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NG Biotech:企業の製品パイプライン分析2018
    Summary NG Biotech is a biotech company that develops and manufactures novel in vitro diagnostic tools for therapy monitoring. The company’s products include whole blood pregnancy tests, M-health malaria tests, NG Test readers, antibiotic resistance tests, and OTC tests. It also develops a proprieta …
  • Surgical Care Affiliates LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …
  • The Cato Corporation:企業の戦略・SWOT・財務情報
    The Cato Corporation - Strategy, SWOT and Corporate Finance Report Summary The Cato Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Travelzoo Inc.:企業の戦略・SWOT・財務情報
    Travelzoo Inc. - Strategy, SWOT and Corporate Finance Report Summary Travelzoo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Shui On Land Limited:企業の戦略・SWOT・財務情報
    Shui On Land Limited - Strategy, SWOT and Corporate Finance Report Summary Shui On Land Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Applied Medical Resources Corporation:企業の戦略的SWOT分析
    Applied Medical Resources Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Glanbia Nutritionals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Glanbia Nutritionals Inc (Glanbia Nutritionals) is a global provider of nutritional ingredients, functional ingredients, and customized premix solutions. The company manufactures and markets customized micronutrient blends, vitamins, minerals, amino acids, colors and specialty ingredients. T …
  • Firstec Co., Ltd.
    Firstec Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Firstec Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kia Motors Corporation:企業の戦略・SWOT・財務分析
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dune Medical Devices Ltd:企業の製品パイプライン分析2018
    Summary Dune Medical Devices Ltd (Dune Medical), a subsidiary of Dune Medical Devices Inc, is a medical device company that offers diagnostic products. The company develops, manufactures, and commercializes tissue characterization devices including MarginProbe system that provides assessment of the …
  • Sutter Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Fr …
  • Senvion SA-エネルギー分野:企業M&A・提携分析
    Summary Senvion S.A. (Senvion), formerly Senvion S.a.r.l, is a renewable energy company that develops, produces and distributes onshore and offshore wind turbines and towers. It also offers project specific solutions such as turnkey , foundation construction, transport and installation, and service …
  • Moberg Pharma AB (MOB)-医療機器分野:企業M&A・提携分析
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB is a pharmaceutical company that offers medical products for the treatment of skin diseases. The company offers products which include Emtrix, Nalox and Naloc, Kerasal nail, Kerasal foot ointment, Domeboro, Blamex and Balmex adult ca …
  • British Columbia Ferry Services Inc.:企業の戦略的SWOT分析
    British Columbia Ferry Services Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Anadolu Anonim Turk Sigorta Sirketi:企業の戦略・SWOT・財務情報
    Anadolu Anonim Turk Sigorta Sirketi - Strategy, SWOT and Corporate Finance Report Summary Anadolu Anonim Turk Sigorta Sirketi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Smithfield Foods Inc:企業の戦略・SWOT・財務情報
    Smithfield Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Smithfield Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AnaMar AB:医療機器:M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …
  • Tokyo Gas Co Ltd (9531)-石油・ガス分野:企業M&A・提携分析
    Summary Tokyo Gas Co Ltd (Tokyo Gas) is a gas utility that produces, supplies and markets liquefied natural gas (LNG). It also produces, supplies and sells electricity. Tokyo Gas also has overseas upstream, midstream and downstream businesses. It provides engineering solutions, gas appliances and ga …
  • Kaiser Foundation Health Plan Inc:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • WestWind Energy Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary WestWind Energy Pty Ltd (West Wind) is a renewable energy company that offers development, construction, operation and management of wind farms and other energy projects. The company provides energy consultation, planning, and maintenance services. It also operates and maintains wind turbine …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆